lobbying_filings_raw: ebd85b00-efc8-41c8-a2db-5f45fea5df28
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ebd85b00-efc8-41c8-a2db-5f45fea5df28 | 2T | 41454 | WILLIAMS AND JENSEN, PLLC | 151548 | VERTEX PHARMACEUTICALS INCORPORATED | 2023 | second_quarter | 2023-07-14T11:54:22-04:00 | 20000.0 | 0 | 0 | 1 | {"url": "https://lda.senate.gov/api/v1/filings/ebd85b00-efc8-41c8-a2db-5f45fea5df28/", "filing_uuid": "ebd85b00-efc8-41c8-a2db-5f45fea5df28", "filing_type": "2T", "filing_type_display": "2nd Quarter - Termination", "filing_year": 2023, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/ebd85b00-efc8-41c8-a2db-5f45fea5df28/print/", "filing_document_content_type": "text/html", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Isabella Quinn", "dt_posted": "2023-07-14T11:54:22-04:00", "termination_date": "2023-05-31", "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1201 Pennsylvania Avenue, NW", "registrant_address_2": "Suite 800", "registrant_different_address": true, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 41454, "url": "https://lda.senate.gov/api/v1/registrants/41454/", "house_registrant_id": 30771, "name": "WILLIAMS AND JENSEN, PLLC", "description": "Lobbying Law Firm", "address_1": "1201 Pennsylvania Avenue, NW", "address_2": "Suite 800", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ISABELLA QUINN", "contact_telephone": "+1 202-659-8201", "dt_updated": "2026-01-30T10:10:58.206597-05:00"}, "client": {"id": 151548, "url": "https://lda.senate.gov/api/v1/clients/151548/", "client_id": 1006613, "name": "VERTEX PHARMACEUTICALS INCORPORATED", "general_description": "Pharmaceutical", "client_government_entity": false, "client_self_select": null, "state": "MA", "state_display": "Massachusetts", "country": "US", "country_display": "United States of America", "ppb_state": "MA", "ppb_state_display": "Massachusetts", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2015-02-20"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": "Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": "Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": "Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "General education about policies to improve outcomes for patients with APOL-1 kidney disease.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": "Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 30771 | MA | MA | US | US | Pharmaceutical | 0 | 0 | 2067154 | normalized_name_state | 0.9 |